InvestSMART

Chrysos Corporation Limited (ASX:C79)

ALERT: Price-sensitive ASX Announcement for C79
Current share price for C79 : $7.080 0.63 (9.77%)+
Announcement
Release
11 Aug 2026 8:42AM
Price at Release
$6.450
Full Release
download
Summary
Chrysos Corporation Limited reported significant growth in its Full Year Results for FY26, achieving a revenue of $88.1 million, marking a 33% increase over the previous year. This growth was supported by the widespread adoption of its PhotonAssayTM technology, which also led to a 68% increase in EBITDA to $27.2 million. The company deployed seven new PhotonAssayTM units in FY26, bringing the total to 46 units, and secured 24 new lease agreements. Despite facing foreign exchange headwinds, Chrysos maintained strong financial health with $25.9 million in cash and $140 million in undrawn debt, positioning itself well for future expansion with plans to manufacture 18 units annually. Record sample volumes were achieved, with a year-on-year growth of 67%, underscoring the increasing demand for Chrysos' innovative assaying solutions.
Key Points
  • Revenue reached $88.1 million, a 33% increase from FY25, driven by global adoption of PhotonAssayTM technology.
  • EBITDA grew by 68% year-on-year to $27.2 million with a margin expansion from 24% to 31%.
  • 46 PhotonAssayTM units are currently deployed with seven new units deployed in FY26.
  • The company maintained a strong funding position with $25.9 million in cash and $140 million in undrawn debt.
  • Chrysos Corporation Limited signed 24 new lease agreements in FY26, expanding its global footprint.
  • Record sample volumes were achieved, with a 67% year-on-year increase.
  • Chrysos Corporation aims to increase its manufacturing cadence to 18 units per year to support future growth.
  • The company managed to achieve the upper end of its FY26 guidance despite foreign exchange headwinds.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.